Grantham, Mayo, Van Otterloo & Co (GMO)
VRSN icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s VeriSign VRSN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio VRSN Stock Details VRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,326
Closed -$1.29M – 731
2025
Q4 		$1.29M Buy
5,326
+2,253
+73% +$566K ﹤0.01% 473
2025
Q3 		$859K Buy
3,073
+1,573
+105% +$440K ﹤0.01% 494
2025
Q2 		$433K Buy
+1,500
New +$406K ﹤0.01% 547

Other funds holding VRSN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s VRSN Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of VeriSign (VRSN) in Q1 2026, closing a stake of 5,326 shares — an estimated $1.29M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VRSN in Q2 2025 and held it in 3 quarters. The position peaked at $1.29M in Q4 2025. 852 funds tracked by Wall St. Rank hold VRSN as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining VeriSign position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,326 VeriSign shares in Q1 2026, an estimated $1.29M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VeriSign in Q2 2025 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s VeriSign position peaked at $1.29M in Q4 2025.
  • 852 funds tracked by Wall St. Rank held VeriSign as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.